The term "YDR274C" corresponds to a systematic gene identifier in Saccharomyces cerevisiae (yeast), representing a specific chromosomal locus. In standard nomenclature:
Y: Indicates yeast (Saccharomyces)
D: Chromosome IV
R: Right arm of the chromosome
274: 274th open reading frame (ORF)
C: Indicates the Watson strand orientation
This designation does not inherently describe an antibody but rather a genomic locus. Antibodies are typically named based on their target antigen (e.g., anti-HER2) or assigned unique identifiers by commercial vendors/research institutions (e.g., "Catalog #AB1234").
The provided sources extensively discuss antibodies targeting viral proteins (HIV, SARS-CoV-2), cancer antigens, and immune checkpoints but do not mention YDR274C:
HIV Antibodies: Sources and detail CD4-binding-site antibodies like N6 and VRC07-523LS, which neutralize HIV through distinct mechanisms .
Cancer Therapies: Bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs) are highlighted in sources and , focusing on targets like EGFR and HER2 .
Antibody Validation: Source emphasizes challenges in commercial antibody reliability, while source describes resurrecting antibodies for protein studies .
No studies in the provided materials investigate antibodies targeting yeast-derived proteins or gene products labeled "YDR274C."
If "YDR274C Antibody" refers to an antibody targeting the protein encoded by the YDR274C gene, this protein (if characterized) would require validation in peer-reviewed studies. No such data exists in the reviewed sources.
Yeast proteins are occasionally used as model antigens, but antibodies against them are rarely assigned systematic gene identifiers as primary names.
The term might describe an antibody under development by a private entity or academic lab that has not yet been published or deposited in public databases.
Commercial antibody vendors (e.g., Thermo Fisher, Abcam) were not represented in the search results, suggesting a gap in accessible data.
To resolve this ambiguity:
Consult Specialized Databases:
UniProt: Search for YDR274C-associated proteins (e.g., UniProt entry P40031).
Antibody Registries: Use the Antibody Registry to cross-reference identifiers.
Yeast Genome Database: Explore functional annotations for YDR274C at SGD.
Contact Commercial Vendors:
Inquire directly with antibody suppliers (e.g., ABCAM, CST) about antibodies raised against the YDR274C-encoded protein.
Review Preprint Servers: Search platforms like bioRxiv for unpublished studies using "YDR274C Antibody."
YDR274C refers to a specific open reading frame in Saccharomyces cerevisiae (strain ATCC 204508/S288c), commonly known as Baker's yeast. The gene encodes a protein tracked in the UniProt database under accession number P87283 . The significance of YDR274C lies in its role within fundamental cellular processes in yeast, making it an important target for researchers studying eukaryotic cell biology. Antibodies against this protein allow visualization and quantification of expression patterns under various experimental conditions.
When designing experiments involving YDR274C, researchers should consider that this protein, like many yeast proteins, may have homologs in other organisms that could be relevant for comparative studies. The antibody serves as a powerful tool for understanding protein function, localization, and interactions within the cellular context of this model organism.
When designing your first experiment with YDR274C antibody, begin with a clear hypothesis about the protein's behavior under your experimental conditions. Start with standard protocols established in the literature and include proper controls:
Positive control: Use a wild-type yeast strain known to express YDR274C
Negative control: Include a YDR274C deletion strain
Secondary antibody-only control: To assess non-specific binding
For initial characterization, perform Western blot analysis to confirm the antibody's specificity for YDR274C. Use the following experimental design template:
| Experimental Group | Sample Preparation | Antibody Dilution | Detection Method | Expected Result |
|---|---|---|---|---|
| Wild-type strain | Standard lysis buffer | 1:1000 (primary) | Chemiluminescence | Single band at predicted MW |
| YDR274C deletion | Standard lysis buffer | 1:1000 (primary) | Chemiluminescence | No band |
| Secondary control | Standard lysis buffer | No primary, 1:5000 secondary | Chemiluminescence | No band |
After confirming specificity, progress to immunofluorescence or other detection methods based on your research question. Remember that storage conditions significantly impact antibody performance - store undiluted at 4°C and protect from prolonged light exposure as typically recommended for antibody preparations .
YDR274C antibodies should be stored according to standard antibody preservation protocols to maintain optimal activity. Store the antibody undiluted at 4°C and protect it from prolonged exposure to light . Do not freeze the antibody unless specifically recommended by the manufacturer, as repeated freeze-thaw cycles can lead to protein denaturation and loss of binding efficiency.
For handling:
Always wear gloves to prevent contamination
Centrifuge briefly before opening to collect all liquid at the bottom of the tube
Use sterile pipette tips when removing aliquots
If dilution is necessary, use a high-quality buffer recommended for antibody dilution
For long-term storage (>1 month), consider creating small single-use aliquots to avoid repeated freeze-thaw cycles if freezing is required
When designing multi-day experiments, prepare a working dilution fresh each day rather than storing diluted antibody. Track the performance over time by maintaining detailed records of experimental outcomes to identify any deterioration in antibody function.
Specificity issues with YDR274C antibody in complex yeast lysates require systematic troubleshooting. First, verify your negative control using a YDR274C deletion strain, as this should yield no signal. If background bands persist, consider these advanced approaches:
Peptide competition assay: Pre-incubate your antibody with excess YDR274C peptide (the immunogen). This should abolish specific binding while leaving non-specific binding intact, helping identify false positives.
Gradient optimization: Test a broader range of antibody dilutions (1:500 to 1:5000) and blocking conditions (3-5% BSA vs. milk, with varying incubation times).
Cross-adsorption: If you suspect cross-reactivity with related yeast proteins, consider pre-adsorbing your antibody with lysates from strains expressing potential cross-reactive proteins.
Alternative lysis methods: Different extraction protocols may maintain epitope integrity better or reduce non-specific interactions. Compare enzymatic lysis, glass bead disruption, and chemical lysis methods.
Document your troubleshooting systematically using a data table format:
| Troubleshooting Approach | Protocol Modification | Outcome | Interpretation |
|---|---|---|---|
| Antibody dilution | 1:500, 1:1000, 1:2000, 1:5000 | [Results] | [Analysis] |
| Blocking condition | 3% BSA, 5% BSA, 5% milk, 4 hours | [Results] | [Analysis] |
| Lysis method | Enzymatic, mechanical, chemical | [Results] | [Analysis] |
This methodical approach allows identification of the specific source of non-specificity and provides documentation for reproducible protocols.
Cross-reactivity assessment is critical when working with antibodies targeting yeast proteins due to the high conservation of many cellular components. YDR274C antibody should be evaluated within the context of other Saccharomyces cerevisiae antibodies through systematic analysis.
Most yeast antibodies, including anti-YDR274C, demonstrate some degree of cross-reactivity with closely related proteins within the same family or containing similar epitopes. This is particularly relevant for antibodies raised against highly conserved domains. Unlike Anti-Saccharomyces cerevisiae antibodies (ASCA) used in clinical settings for detecting IBD biomarkers , research-grade antibodies like YDR274C antibody target specific intracellular proteins rather than cell wall components.
To assess cross-reactivity:
Perform Western blot analysis on a panel of yeast strains with:
Wild-type expression
YDR274C deletion
Deletions of related genes
Overexpression of YDR274C and related proteins
Analyze the reactivity pattern and document as follows:
| Yeast Strain | YDR274C Status | Primary Band Detection | Secondary Bands | Relative Signal Intensity |
|---|---|---|---|---|
| Wild-type | Native expression | Present (XX kDa) | List if present | +++ |
| YDR274C deletion | Absent | Absent | List if present | - |
| Related gene deletion 1 | Native expression | Present (XX kDa) | Reduced? | ++ |
| YDR274C overexpression | Increased | Present (XX kDa) | List if present | ++++ |
This systematic evaluation provides critical information for experiment design and data interpretation when using YDR274C antibody in complex research applications.
For advanced visualization of YDR274C localization in yeast cells, several sophisticated imaging techniques provide complementary data with different resolution limits and advantages:
Super-resolution microscopy: Techniques like Structured Illumination Microscopy (SIM) or Stochastic Optical Reconstruction Microscopy (STORM) can resolve subcellular structures beyond the diffraction limit, allowing precise localization of YDR274C within yeast compartments.
Correlative Light and Electron Microscopy (CLEM): This hybrid approach combines the specificity of fluorescence microscopy (using YDR274C antibody) with the ultrastructural detail of electron microscopy, ideal for placing YDR274C in the context of cellular ultrastructure.
Live-cell imaging with split fluorescent proteins: While not directly using the antibody, this complementary approach can validate antibody-based localization by tagging YDR274C with half of a fluorescent protein that becomes functional when the protein reaches its native compartment.
Expansion microscopy: This technique physically expands the sample using swellable polymers, increasing effective resolution with standard confocal microscopes.
Comparison of these techniques for YDR274C visualization:
| Imaging Technique | Resolution Limit | Sample Preparation | Live/Fixed Cells | Advantages | Limitations |
|---|---|---|---|---|---|
| STORM | 20-30 nm | Complex, special buffers | Fixed | Highest resolution | Photo-bleaching, complex analysis |
| SIM | 100-130 nm | Standard IF protocol | Both | Less phototoxicity | Less resolution than STORM |
| CLEM | EM: 1-2 nm, LM: 200 nm | Very complex | Fixed | Ultrastructural context | Labor-intensive, specialized equipment |
| Expansion Microscopy | ~70 nm | Specialized embedding | Fixed | Uses standard microscopes | Sample distortion possible |
For optimal results, validate localization patterns with at least two independent techniques and quantify co-localization with known organelle markers.
Designing robust controls for YDR274C antibody immunoprecipitation (IP) experiments is essential for generating reliable, publishable data. A comprehensive control strategy includes:
Genetic Controls:
Wild-type strain (positive control)
YDR274C deletion strain (negative control)
YDR274C-tagged strain (additional positive control with known size shift)
Technical Controls:
Input sample (pre-IP lysate, typically 5-10%)
Non-specific IgG IP (same species as YDR274C antibody)
Beads-only control (no antibody added)
Reciprocal IP if studying protein interactions (IP with antibody against suspected interaction partner)
Treatment Controls:
Untreated condition baseline
Multiple treatment conditions showing dynamic range
Time course if studying temporal interactions
Design your IP experiment with the following structure:
| Control Type | Sample | Purpose | Expected Result | Troubleshooting if Failed |
|---|---|---|---|---|
| Genetic | Wild-type IP | Positive control | YDR274C band present | Check antibody, lysis conditions |
| Genetic | YDR274C deletion IP | Negative control | No YDR274C band | Antibody specificity issue |
| Technical | Input (5%) | Loading/expression control | YDR274C band at 5% intensity of IP | Check protein expression |
| Technical | IgG IP | Non-specific binding control | No YDR274C band | Higher stringency washes needed |
| Technical | Beads only | Resin binding control | No YDR274C band | Change blocking or resin type |
When analyzing interaction partners, always validate with reciprocal IPs and consider using quantitative mass spectrometry to distinguish true interactors from background contaminants. This systematic approach ensures rigorous validation of any interactions identified with YDR274C antibody.
Chromatin immunoprecipitation (ChIP) using YDR274C antibody requires careful optimization due to the unique challenges of yeast cell wall and chromatin access. The following protocol incorporates key optimization steps specific to yeast ChIP:
Sample Preparation:
Culture yeast cells to mid-log phase (OD600 ~0.7-0.8)
Crosslink with 1% formaldehyde for 15 minutes at room temperature
Quench with 125 mM glycine for 5 minutes
Harvest cells and wash twice with cold PBS
Cell Lysis and Chromatin Preparation:
Resuspend in lysis buffer with protease inhibitors
Add glass beads and disrupt cell wall using bead beater (8 cycles, 30 seconds on/30 seconds off)
Recover lysate and perform chromatin shearing via sonication
Verify shearing efficiency (target: 200-500 bp fragments)
Immunoprecipitation:
Pre-clear chromatin with Protein A/G beads for 1 hour
Add YDR274C antibody (5 μg per sample) and incubate overnight at 4°C
Add pre-blocked Protein A/G beads and incubate for 3 hours
Perform increasingly stringent washes
Data Analysis Controls:
Input chromatin (non-immunoprecipitated, typically 5%)
IgG control (non-specific antibody of same isotype)
Positive control region (known binding site, if established)
Negative control region (genomic region not expected to bind)
Results should be analyzed using the percent input method:
| Sample | Target Region Enrichment (% Input) | Negative Region (% Input) | Fold Enrichment | Interpretation |
|---|---|---|---|---|
| YDR274C Ab | X% | Y% | X/Y | Significant if >2-fold |
| IgG Control | Z% | W% | Z/W | Should be ~1 |
For qPCR analysis, design primers spanning potential binding regions and ensure that amplification efficiency is between 90-110%. ChIP-seq would provide genome-wide binding profiles for more comprehensive analysis of YDR274C chromatin interactions.
Quantitative analysis of YDR274C protein levels across experimental conditions requires rigorous methodology to ensure meaningful comparisons. The following approaches provide increasingly sophisticated quantification:
Western Blot Quantification:
Use a standardized loading control (e.g., PGK1, TUB1)
Ensure you're operating in the linear range of detection
Capture images using a digital imager with a wide dynamic range
Quantify band intensities using software like ImageJ
Normalize YDR274C signal to loading control
Run at least three biological replicates for statistical comparison
ELISA-Based Quantification:
Develop a sandwich ELISA using YDR274C antibody as capture antibody
Generate a standard curve using recombinant YDR274C protein
Process samples in technical triplicates
Calculate absolute protein concentrations from the standard curve
Mass Spectrometry-Based Quantification:
Use SILAC or TMT labeling for direct sample comparison
Identify YDR274C-specific peptides for quantification
Normalize to internal standard peptides
Apply appropriate statistical analysis for comparative proteomics
Data Organization:
Create a comprehensive data table following established guidelines :
| Experimental Condition | Replicate 1 (Normalized YDR274C) | Replicate 2 | Replicate 3 | Mean | Standard Deviation | Statistical Significance |
|---|---|---|---|---|---|---|
| Control | Value | Value | Value | Value | Value | N/A |
| Treatment 1 | Value | Value | Value | Value | Value | p-value vs. Control |
| Treatment 2 | Value | Value | Value | Value | Value | p-value vs. Control |
When interpreting results, consider biological significance beyond statistical significance - protein level changes should be evaluated in the context of relevant biological thresholds rather than arbitrary cutoffs. For time-course experiments, apply appropriate regression models rather than multiple pairwise comparisons to better capture trends.
When unexpected bands appear in Western blots using YDR274C antibody, systematic interpretation is necessary to distinguish between biologically meaningful signals and technical artifacts. Follow this decision tree approach:
Step 1: Characterize the unexpected bands
Document precisely:
Molecular weight (apparent kDa)
Intensity relative to expected YDR274C band
Consistency across replicates
Behavior under different experimental conditions
Step 2: Consider biological explanations
Evaluate if bands could represent:
Post-translational modifications (phosphorylation, ubiquitination, etc.)
Alternative splice variants (less common in yeast but possible)
Proteolytic fragments of YDR274C
Protein complexes (if sample preparation used mild detergents)
Step 3: Perform validation experiments
To distinguish between possibilities:
| Validation Approach | Protocol | Expected Result if Biological | Expected Result if Artifact |
|---|---|---|---|
| Phosphatase treatment | Treat lysate with λ-phosphatase before WB | Higher MW bands shift down | No change |
| Protease inhibitor panel | Prepare lysates with different inhibitor combinations | Fragment pattern changes | No change |
| Denaturing conditions | Increase SDS%, add reducing agents | Complex bands resolve to single band | Non-specific bands remain |
| Peptide competition | Pre-incubate antibody with immunizing peptide | All specific bands disappear | Non-specific bands remain |
| Genetic validation | Test YDR274C mutants (deletion, truncation) | Band pattern changes predictably | Random pattern unrelated to modifications |
Step 4: Quantification and reporting
If bands are determined to be biologically relevant:
Quantify all relevant bands separately
Report their relative abundance
Discuss the biological implications of modified forms
This systematic approach transforms potentially confusing results into valuable insights about YDR274C biology and ensures proper interpretation of antibody-based detection.
Preliminary Data Assessment:
Test for normality using Shapiro-Wilk or D'Agostino-Pearson test
Examine homogeneity of variance using Levene's test
Identify and address outliers (consider modified Z-score method)
For Normally Distributed Data:
Two conditions: Student's t-test (paired or unpaired)
Multiple conditions: One-way ANOVA followed by post-hoc tests (Tukey's HSD for all pairwise comparisons, Dunnett's for comparison to control)
Two factors: Two-way ANOVA with appropriate post-hoc analysis
Correlation analysis: Pearson's correlation coefficient
For Non-Normally Distributed Data:
Two conditions: Mann-Whitney U test or Wilcoxon signed-rank test
Multiple conditions: Kruskal-Wallis test followed by Dunn's post-hoc test
Correlation analysis: Spearman's rank correlation
For Time-Course Experiments:
Repeated measures ANOVA
Mixed-effects models
Area under the curve analysis
Sample Size Considerations:
Perform power analysis to determine adequate replicates. For typical Western blot quantification with YDR274C antibody, aim for:
| Expected Effect Size | Minimum Biological Replicates | Technical Replicates per Biological Sample |
|---|---|---|
| Large (>50% change) | 3 | 2 |
| Medium (20-50% change) | 5 | 2-3 |
| Small (<20% change) | 8+ | 3 |
Reporting Standards:
This comprehensive statistical approach ensures robust interpretation of YDR274C protein level variations and facilitates comparison across different studies.